Don’t miss the latest developments in business and finance.

India and Japan to seek regulatory collaboration for medical products

The Japan has extended support to Government of India for Indian regulators' skill enhancement through its Asia Training Centre

medical devices
BS B2B Bureau New Delhi
Last Updated : May 21 2016 | 12:30 PM IST
India and Japan are looking to accelerate collaboration for medical products through increased collaboration between the regulators of the two countries. Against this background, the first ever joint symposium between India and Japan to facilitate regulatory collaboration for medical products was organised by FICCI from May 18-19, 2016 in New Delhi.
 
As India is scaling up its healthcare systems and in parallel streamlining the pharmaceutical and medical devices regulatory guidelines, it is envisaged that harmonisation of regulatory frameworks will benefit trade exchange & technology exchange for larger good. Japan is the third largest medical devices manufacturer and consumer in the world. It is a pioneer for development of several pharmaceutical and medical devices.
 
Japan and India are strong cultural and trade partners, with Japan being the fourth largest FDI contributor to India. Under the agreement held in 2015 between PM Narendra Modi and Japanese PM Shinzo Abe, FDIs from Japan are likely to be doubled by 2019.
 

More From This Section

During the two day symposium, participants from both countries agreed to collaborate more comprehensively in future. The Japanese side has extended support to Government of India for Indian regulators’ skill enhancement through its Asia Training Centre.
 
“This is a great start. We have achieved much needed momentum for our regulators to meet and collaborate. From this point onwards, we collectively commit ourselves to greater partnership and bi-lateral relationship”, said Probir Das, chairman, FICCI Medical Devices Forum.

Also Read

First Published: May 21 2016 | 12:27 PM IST

Next Story